2007
DOI: 10.1093/ajcn/86.5.1670
|View full text |Cite
|
Sign up to set email alerts
|

Treatment for 2 mo with n−3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study

Abstract: Background: Information is lacking on the potential effect of nҀ3 polyunsaturated fatty acids (PUFAs) on the adipose tissue of patients with type 2 diabetes. Objective: We evaluated whether nҀ3 PUFAs have additional effects on adiposity, insulin sensitivity, adipose tissue function (production of adipokines and inflammatory and atherogenic factors), and gene expression in type 2 diabetes. Design: Twenty-seven women with type 2 diabetes without hypertriglyceridemia were randomly allocated in a double-blind para… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

10
180
4
4

Year Published

2009
2009
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 222 publications
(198 citation statements)
references
References 54 publications
10
180
4
4
Order By: Relevance
“…Dyslipidaemia is one of the principal causative factor contributing to the atherogenic processes (Steinberg 2004), and the AI is commonly used as the finest lipid parameter to predict human CVD risk (Vinson et al 2001). The AI lowering effect of n-3 LC-PUFA has been previously reported by Deutch et al (2000) and Kabir et al (2007) in women, and our data confirm the importance of EPA and DHA in the prevention of dyslipidaemia and related diseases, emphasizing the need of a better understanding of the molecular process involved.…”
Section: Discussionsupporting
confidence: 84%
“…Dyslipidaemia is one of the principal causative factor contributing to the atherogenic processes (Steinberg 2004), and the AI is commonly used as the finest lipid parameter to predict human CVD risk (Vinson et al 2001). The AI lowering effect of n-3 LC-PUFA has been previously reported by Deutch et al (2000) and Kabir et al (2007) in women, and our data confirm the importance of EPA and DHA in the prevention of dyslipidaemia and related diseases, emphasizing the need of a better understanding of the molecular process involved.…”
Section: Discussionsupporting
confidence: 84%
“…Fish contains omega 3 (n-3) polyunsaturated fatty acids and high-density lipoprotein-cholesterol (Kabir et al, 2007), which has been positively correlated with SHBG (Thomas et al, 1999). A low intake of fish by our study subjects (median, 1.5 times per week) may make it difficult to detect an association for this food group.…”
Section: Discussionmentioning
confidence: 85%
“…Another dietary approach in the prevention of diabetes is the Mediterranean diet, rich in olive oil, which may provide cardiovascular benefits (49) . Manipulation of dietary fat quality by increasing the MUFA content or the n-3 or n-6 long-chain PUFA content of the diet in intervention studies has not shown consistent results on insulin sensitivity (40)(41)(42)(43) . Based on the earlier findings on FA handling and insulin sensitivity in different prediabetic states, it can be speculated that effectiveness of dietary fat manipulation may depend on initial metabolic phenotype.…”
Section: Long-term Dietary Intervention Manipulating Diet Compositionmentioning
confidence: 99%
“…There are indications that dietary fat quality may have an impact on pathways of FA handling and insulin sensitivity. Indeed, dietary intervention, including a reduction in SFA, has been shown to improve insulin sensitivity (38,39) , possibly through effects on muscle lipid handling, although data are not consistent (40)(41)(42)(43) . PUFA may reduce lipid overflow through inducing adipocyte differentiation thereby increasing lipid uptake as shown in a human preadipocyte cell line (44) .…”
Section: Dietary Fat Quality and Skeletal Muscle Fatty Acid Handlingmentioning
confidence: 99%